Donald N. Forthal
Division of Infectious Diseases
Department of Medicine
University of California
Irvine School of Medicine
USA
Name/email consistency: high
- Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12. Forthal, D.N., Gach, J.S., Landucci, G., Jez, J., Strasser, R., Kunert, R., Steinkellner, H. J. Immunol. (2010)
- Fc receptor-mediated antiviral antibodies. Forthal, D.N., Moog, C. Curr. Opin. HIV. AIDS (2009)
- FcgammaRIIa genotype predicts progression of HIV infection. Forthal, D.N., Landucci, G., Bream, J., Jacobson, L.P., Phan, T.B., Montoya, B. J. Immunol. (2007)
- Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate. Forthal, D.N., Gilbert, P.B., Landucci, G., Phan, T. J. Immunol. (2007)
- Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells. Forthal, D.N., Landucci, G., Cole, K.S., Marthas, M., Becerra, J.C., Van Rompay, K. J. Virol. (2006)
- Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1. Forthal, D.N., Landucci, G., Phan, T.B., Becerra, J. J. Virol. (2005)
- Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count. Forthal, D.N., Landucci, G., Keenan, B. AIDS Res. Hum. Retroviruses (2001)
- Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells. Forthal, D.N., Landucci, G., Daar, E.S. J. Virol. (2001)
- Antibody inhibition of cytomegalovirus: the role of natural killer and macrophage effector cells. Forthal, D.N., Phan, T., Landucci, G. Transpl. Infect. Dis (2001)
- Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. Forthal, D.N., Landucci, G., Haubrich, R., Keenan, B., Kuppermann, B.D., Tilles, J.G., Kaplan, J. J. Infect. Dis. (1999)
- In vitro reduction of virus infectivity by antibody-dependent cell-mediated immunity. Forthal, D.N., Landucci, G. J. Immunol. Methods (1998)